AMH as part of the diagnostic PCOS workup in large epidemiological studies
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objectives: Previous studies have shown good correlation between polycystic ovarian morphology (PCOM) and serum anti-Müllerian hormone (AMH) levels. We evaluated the utility of AMH as a surrogate for PCOM as a part of the polycystic ovary syndrome (PCOS) diagnosis by describing how the use of different AMH cut-off values would change the prevalence of PCOS. Methods: A general population-based birth cohort study. Anti-Müllerian hormone concentrations were measured from serum samples taken at age 31 years (n = 2917) using the electrochemiluminescence immunoassay (Elecsys). Anti-Müllerian hormone data were combined with data on oligo/amenorrhoea and hyperandrogenism to identify women with PCOS. Results: The addition of AMH as a surrogate marker for PCOM increased the number of women fulfilling at least two PCOS features in accordance with the Rotterdam criteria. The prevalence of PCOS was 5.9% when using the AMH cut-off based on the 97.5% quartile (10.35 ng/mL) and 13.6% when using the recently proposed cut-off of 3.2 ng/mL. When using the latter cut-off value, the distribution of PCOS phenotypes A, B, C, and D was 23.9%, 4.7%, 36.6%, and 34.8%, respectively. Compared with the controls, all PCOS groups with different AMH concentration cut-offs showed significantly elevated testosterone (T), free androgen index (FAI), luteinizing hormone (LH), LH/follicle-stimulating hormone (FSH) ratio, body mass index (BMI), waist circumference, and homoeostatic model assessment of insulin resistance (HOMA-IR) values, as well as significantly decreased sex hormone-binding globulin (SHBG) values. Conclusions: Anti-Müllerian hormone could be useful surrogate for PCOM in large data sets, where transvaginal ultrasound is not feasible, to aid the capturing of women with typical PCOS characteristics. Anti-Müllerian hormone measurement from archived samples enables retrospective PCOS diagnosis when combined with oligo/amenorrhoea or hyperandrogenism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Self-citationMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Pigny, P., Jonard, S., Robert, Y., & Dewailly, D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2076 · Cited by 471
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434
Self-citationThe antral follicle count: practical recommendations for better standardization
Broekmans, F. J. M., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.040 · Cited by 414
Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Future and existing data sets should identify PCOS status, including self-report, PCOS symptoms and, ideally, androgen and AMH measurement 28 .”
Self-citationOllila, M.-M., Arffman, R. K., Korhonen, E., Morin-Papunen, L., Franks, S., Junttila, J., & Piltonen, T. T. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad077 · Cited by 108
Self-citationvan der Ham, K., Laven, J. S. E., Tay, C. T., Mousa, A., Teede, H. J., & Louwers, Y. V. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.05.163 · Cited by 102
“In addition, for detecting PCOM, different thresholds have been tested in previously published studies (101, 116).”
The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment
Ghafari, A., Maftoohi, M., Samarin, M. E., Barani, S., Banimohammad, M., & Samie, R. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100228 · Cited by 92
International evidence‐based guideline on assessment and management of PCOS —A Nordic perspective
Forslund, M., Melin, J. M., Stener‐Victorin, E., Hirschberg, A. L., Teede, H. J., Vanky, E., & Piltonen, T. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14725 · Cited by 69
Self-citation
Metadata
- Authors
- Piltonen, T. T., Komsi, E., Morin-Papunen, L. C., Korhonen, E., Franks, S., Järvelin, M.-R., Arffman, R. K., & Ollila, M.-M.
- Affiliations
- Oulu University Hospital (FI)
- Imperial College London (GB)
- Corresponding author
- Piltonen, Terhi T
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-06
- Volume
- 188
- Issue
- 6
- Pages
- 547-554
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W4380146550
- Cited by
- 58
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 19 · 2023: 7
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Academy of Finland (315921, 321763, Profi6 336449)
- Sigrid Juselius Foundation
- Medical Research Center Oulu
- Novo Nordisk Foundation
- Roche Diagnostics International Ltd
- University of Oulu (65354)
- Oulu University Hospital (2/97, 8/97)
- Ministry of Health and Social Affairs (23/251/97, 160/97, 190/97)
- National Institute for Health and Welfare (54121)
- Regional Institute of Occupational Health, Oulu, Finland (50621, 54231, 24000692, 24301140)
- European Regional Development Fund (539/2010 A31592)
- DynaHEALTH (633595)
- LifeCycle (733206)
- LongITools (873749)
- EDCMET (825762)
- Medical Research Council, UK (MRC/BBSRC MR/S03658X/1)
- MRC (MR/S019669/1)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, anti-Müllerian hormone, polycystic ovary morphology, PCOS diagnostic criteria, PCOS prevalence, PCOS phenotypes, hyperandrogenism, insulin resistance, sex hormone-binding globulin, retrospective diagnosis
- MeSH terms
- Amenorrhea, Female, Humans, Luteinizing Hormone, Polycystic Ovary Syndrome, Retrospective Studies, Cohort Studies, Hyperandrogenism, Anti-Mullerian Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMH as part of the diagnostic PCOS workup in large epidemiological studies. https://app.cochat.ai/papers/10.1093/ejendo/lvad065
- The paper
- Piltonen, T. T., Komsi, E., Morin-Papunen, L. C., Korhonen, E., Franks, S., Järvelin, M.-R., Arffman, R. K., & Ollila, M.-M. (2023). AMH as part of the diagnostic PCOS workup in large epidemiological studies. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad065
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.